.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Hormonal suppression effectively manages endometriosis symptoms and chronic pain. However, many clinicians express concern regarding endometriosis treatment bone health outcomes. Consequently, a recent systematic review published in Obstetrics & Gynecology evaluates how medical therapies influence bone mineral density (BMD).
Specifically, researchers analyzed 37 clinical studies after screening over 1,000 papers. Furthermore, the pooled results showed that GnRH agonists significantly reduced BMD after 12 months of use. In addition, both leuprolide and goserelin treatments led to a notable decrease in bone mass. Although add-back therapy helps, BMD nevertheless declined in most patients because of severe estrogen suppression. Similarly, dienogest also impacted bone health. For example, it was associated with lower BMD at both 6 and 12 months. Consequently, doctors should monitor these patients closely during treatment. Moreover, GnRH antagonists showed a significant decrease, particularly without add-back protocols. Therefore, clinicians must assess bone risks before starting long-term therapy.
Additionally, Indian guidelines from the Indian Fertility Society recommend limiting GnRH analogs since they cause significant bone loss. Furthermore, the ICMR "EndoCare India" model supports standardized care and regular screening. Thus, these proactive steps help ensure that bone preservation remains a clinical priority. Consequently, doctors must balance effective pain relief with the risk of future fractures. Moreover, regular BMD screening and nutritional support are essential for high-risk individuals. In summary, expert consensus is needed for better long-term bone management.
Based on the meta-analysis, GnRH antagonists without add-back therapy showed the largest BMD decrease at six months. Although GnRH agonists and dienogest also cause loss, the lack of add-back therapy significantly worsens the impact on bone mineral density.
Yes, add-back therapy is highly effective because it provides a low level of estrogen to protect the bones. However, it does not completely eliminate bone loss. Therefore, clinicians should still perform regular monitoring during extended treatment cycles.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A systematic review indicates that hormonal treatments for endometriosis, including GnRH agonists and dienogest, significantly decrease bone mineral density...
4 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
